INTRODUCTION
Toward the close of the 20th century, several wealthy democracies experienced profound growth in foster care caseloads (e.g., Department of Health 2000; Swann and Sylvester 2006) . In the United States, for instance, the number of caseloads increased from 276,000 in 1985 to 568,000 in 1999 (Swann and Sylvester 2006:309) . Since the early 2000s, however, caseloads have decreased in countries such as Denmark and the United States (Cunningham and Finlay 2013; Fallesen, Emanuel, and Wildeman 2014; Wildeman and Emanuel 2014) . Yet the causes of these declines remain, for the most part, a mystery.
The logical starting point in understanding these declines is the predictors of foster care caseloads. Researchers have to date focused on two distinct types of factors that shape caseloads. First, they have identified a range of negative parenting behaviors-driven by a combination of poverty, unemployment, drug use and abuse, poor mental health, homelessness, and single motherhood-that increase the risk of foster care placement for individual children and foster care caseloads (Barbell and Freundlich 2001; Cunningham and Finlay 2013; Paxson and Waldfogel 2002 ; for a review, see Wildeman and Waldfogel 2014) . Second, they have focused on how social policies affect caseloads, finding that more generous adoption subsidies and welfare payments decrease caseloads, while increases in imprisonment increase caseloads (Andersen and Wildeman 2014; Berger and Waldfogel 2004; Bitler, Gelbach, and Hoynes 2006; Buckles 2013; Paxson and Waldfogel 2003; Swann and Sylvester 2006 ; for a review, see Wildeman and Waldfogel 2014) . However, because neither the micro-level nor the macro-level conditions discussed above shifted markedly over this period, these factors cannot fully account for the dramatic decline in caseloads that some countries have recently experienced.
In this article, we introduce a third possible cause of this decline: shifts in the share of children with extreme enough behavioral problems that parenting them is exceedingly difficult (Barbell and Freundlich 2001) . Children entering foster care display far higher levels of attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder, depression, mania, and posttraumatic stress disorder than do other children (McMillen et al. 2005) . They are also more likely to score within the clinical range of the Child Behavior Checklist than are other children, with older children in foster care scoring the highest (Burns et al. 2004) . Although the children who eventually end up in foster care disproportionately present symptoms of-and are diagnosed with-a range of serious behavioral and mental health problems, relatively little research has considered how shifts in the behavioral problems of children could affect foster care caseloads.
Based on recent research on how medical treatment of ADHD affects children (Currie, Stabile, and Jones 2013; Government of Western Australia, Department of Health 2010) and the relative distrust of the medical treatment of behavioral problems by medical sociologists (e.g., Conrad 1975 Conrad , 1982 Conrad , 1992 , this inattention is not surprising. Indeed, some of the most rigorous and long-term studies in this area have found that treating children on the margin has substantial negative effects on the learning and behavioral issues of these children (Currie et al. 2013;  Government of Western Australia 2010)-exactly the opposite of the intended result. However, research from countries with markedly lower prescription rates of ADHD medication (such as Denmark) has found that medical treatment of ADHD not only significantly decreases family strain (Kvist, Nielsen, and Simonsen 2013; Schermerhorn et al. 2012 ), but also risky behavior (Chang et al. 2014; Dalsgaard, Nielsen, and Simonsen 2013b) . These findings suggest that increasing medical treatment of ADHD could lead to declines in foster care caseloads-provided the baseline treatment level is quite low making it less likely that over-treatment is an issue.
In this article, we contribute to the discussion of how children's behavioral problems affect foster care caseloads by using Danish registry data to test how medical treatment of ADHD affects foster care caseloads. In order to provide this test, we use annual medical, child welfare, and population data on all Danish municipalities from 1998 to 2010 to examine whether the increased medical treatment of ADHD with prescription drugs like Ritalin led to declining caseloads in Denmark. Our results suggest that after taking observable municipality characteristics, year fixed effects, and municipality fixed effects into account, fully 45 percent of the decrease in Danish caseloads was attributable to increased use of ADHD medication. In comparison, in their seminal article on the causes of the increase in foster care caseloads in the United States, Swann and Sylvester (2006) found that the increase in female imprisonment accounted for 31 percent of the increase in caseloads between 1985 and 2000. To account for possible confounding driven by compositional changes in the child population, we also examine the effect of the rise in ADHD medication on children's individual level risk of being in care.
Here, we find that a child's risk of entering foster care decreased 0.8 percentage points when the share of medicated children increased 1.0 percentage point, a large individual-level response that strengthens our macro-level findings-even if it cannot completely assuage concerns about the ecological fallacy, unfortunately. To further test the robustness of the findings, we also run instrumental variable regressions. These corroborate our other findings, so for the sake of brevity we do not report them in detail.
Taken together, the results of our analysis suggest that medical treatment of ADHD has substantial effects on caseloads. Moreover, the results suggest that interventions that address children's acute behavioral problems may diminish caseloads dramatically. In so doing, they show that while parental behaviors and characteristics, welfare generosity, and the female imprisonment rate all shape foster care caseloads, future research should be more attentive to the ways in which medical treatment aimed at addressing children's acute behavioral problems could also have a powerful effect on foster care caseloads.
BACKGROUND Foster Care in Denmark
The share of Danish children in foster care on any given day has been remarkably stable over the last 100 years (Ebsen and Andersen 2010) , with roughly 1 percent of all Danish children in foster care any given day. The cumulative risk of entering foster care at any point during childhood has, however, decreased for Danish children since 2000 , indicating a decline in first admissions to foster care. Figure 1 shows changes in the cumulative risk of foster care placement for Danish children from 1998 until 2010 across ages 0 to 18. While the cumulative risk was .06 in 2000, by the 2010, the cumulative risk had declined to roughly .03-a 50 percent decline in only a 10 year period, predominantly driven by a decrease in teenage admissions . The cumulative risk for boys decreased more than for girls. For the same period the US experienced only a very slight decline in the cumulative risk of foster care placement, but saw substantial decline in median age of first entrance into foster care and foster In Denmark, foster care is a social service program aimed at providing children with a substitute living arrangement if social services deem the children's parents unable to provide proper care or a child's parents no longer feel capable of providing proper care. Local municipalities manage foster care, with social workers and representatives of the municipal government having the final say in whether or not to instigate a placement. The state provides funding as a specific grant to each municipality, and funding levels have remained constant for the period we consider (Andersen, Madsen and Enemark 2013) . Between 85 and 90 percent of Danish foster care placements are instigated with parental consent (Ebsen and Andersen 2010;  although Hestbaek 1999 shows there is a grey area of voluntary placement that are de facto involuntary), and the risk of first entry is highest among teenagers, followed by infants . The use of voluntary placements and high share of first-timers among teenagers stand in stark contrast to the United States, where infants have by far the highest risk of first entry and where parental consent is considered relevant only when the parent requests the placement, a rare event.
As in other wealthy democracies, Danish children in foster care are more likely to come from single-parent families; their mothers are more likely to be on disability pension, welfare, or unemployment benefits; and their parents are more likely to have been incarcerated at some point (Andersen and Wildeman 2014; Ejrnaes, Ejrnaes, and Frederiksen 2010) . Danish children in foster care are also markedly more likely to suffer from a host of behavioral and mental health problems, including disorders such as ADHD, the diagnosing of which often preceded-and possibly precipitated-the child's eventual foster care placement (Egelund and Laustsen 2009 ). There is also substantial geographical variation in ADHD medication usage. Figure 3 shows the share of children who filled a prescription for ADHD medication across Danish municipalities for the years 1998, 2004, and 2010 . While the intensity maps mirror the overall rise in medication use, they also show substantial differences between municipalities. These differences are most pronounced in 2010, where some municipalities continued to have fewer than 3 per 1,000 children receiving medical treatment for ADHD, while others had up to 31 per 1,000 children receiving it. This is in line with the literature on geographical variation in the adoption of medical technologies (see Nattinger et al. 1992; Gelijns and Rosenberg 1994 
ADHD Treatment as a Protective Factor
Suffering from ADHD thus appears to be a possible contributing cause to foster care placement.
Medical treatment of ADHD increased at the same time foster caseloads declined dramatically and appears to be designed to treat precisely the children who disproportionately enter foster care. Increasing medical treatment of ADHD in countries like Denmark, therefore, might cause fewer children to enter foster care, provided medical treatment of ADHD directly or indirectly improves behavior. Earlier studies of the effect of medical treatment of ADHD on behavior partly corroborate this hypothesis, as medical treatment of ADHD has been shown to cause children suffering from ADHD to have fewer emergency room visits and to commit fewer crimes (Dalsgaard et al. 2013b) , do better in school (Scheffler et al. 2009; Keilow, Holm and Fallesen 2014) , and (as adults) get into fewer traffic accidents (Chang et al. 2014) , to name just three possible benefits.
Yet despite some clear benefits of medical treatment of ADHD, other research shows harmful effects when treating a large proportion of the child population (Currie et al. 2013; Government of Western Australia 2010) . In one especially provocative study, Currie et al. (2013) show that increasing the share of a population that receives ADHD medication can lead to lower educational attainment among boys and higher levels of emotional problems among girls when a large number of children in the population were already medicated for ADHD. On balance, therefore, it seems that the benefits of medical treatment of ADHD are most pronounced in a positive direction when very few children in the population are medicated. Beyond this initial point, the effects may even change course since treating too large a proportion of a child population would be the equivalent of giving stimulants to children who would respond to these stimulants not with greater focus, but with less focus. As we speculate in more detail below, it might be that the US is on the other side of such a tipping point compared to Denmark, or that the US may be treating the wrong part of the population.
Obstacles to Causal Inference
Although analyses of the effects of medical treatment of ADHD on children's behavioral outcomes provide suggestive evidence of a link between medical treatment of ADHD and foster care placement, there are a host of possible confounders that an analysis must account for to render a causal relationship likely. First, children whose families have low SES, who were low birth weight babies, and who had mothers who smoked during pregnancy, for instance, are markedly more likely both to be diagnosed with ADHD and to be placed in foster care at some point (e.g. Ejrnaes et al. 2010; Langley et al. 2007; Swanson et al. 2007) . Therefore, to convincingly render a causal link between medical treatment of ADHD and foster care caseloads probable, we would ideally have macro-level analyses (to show how population-level shifts in ADHD medication shape foster care caseloads) and micro-level analyses (to show that we fully adjust for individual-level factors shaping ADHD diagnosis and foster care placement).
Second, social services may be less inclined to place a child in foster care if they are already receiving medical treatment for ADHD. In such a case, it would not be the treatment of behavioral issues that drove the decrease in foster care, but the labeling effect of a diagnosis. Yet research shows that treating ADHD with Ritalin or similar drugs may have substantial impact on child and family characteristics known to affect the risk of entering foster care (Chang et al. 2014; Dalsgaard et al. 2013b; Kvist et al. 2013; Schermerhorn 2012) , implying that not all of any detected effects should be due to labeling.
Third, if other confounding factors affected both foster care caseloads and the use of ADHD medication, this could lead to confounding bias. Denmark did not enact any policies over the study period that aimed at lowering foster care rates while increasing treatment of behavioral issues (Hestbaek 2011) . Neither is there any evidence of any medical policies directly affecting or causing the increase in ADHD medication rates (Dalsgaard et al. 2013a; Pottegård et al. 2013 ).
In addition, health services and child welfare services receive their funding from different parts of both the municipal and state budget, so informal substitution of funding from social services to health services is also not likely (see Christiansen 2002; Pedersen, Christiansen and Bech 2005 for details on the Danish Health Services). However, we cannot fully reject that other reforms or similar confounding factors may have affected both medication rates and foster care
caseloads. Thus, we must rely on that controlling for observable and time-constant unobservable factors together with robustness tests can render such confounding improbable. We have, however, also run instrumental variable estimations (in appendix in the interest of reserving space) that give us additional confidence in our estimates.
DATA Foster Care Caseloads
All Danish municipalities have reported all instances of instigation or conclusion of a foster care case to Statistics Denmark since 1977. Because these data originate from administrative registers used in the processing of all cases and undergo a thorough control before Statistics Denmark makes them available to researchers, the data have high validity, and there is no sample selection or attrition issues because the data include all children in foster care (Statistics Denmark 2013).
The dependent variable used is the logarithm of the annual foster care caseload (per 1,000)
for each Danish municipality measured each year from 1998 to 2010. 4 We log-transform foster care caseloads because the variable is highly skewed. However, all results are robust to using an untransformed version of the variable (results available upon request). We measure the foster care caseload as the number of children in foster care during the year per 1,000 children from age 0 to age 17 from a given municipality. Table 1 reports summary statistics for foster care caseloads, as well as the explanatory variables discussed in the next subsection.
[ Table 1 about here.]
Measuring Medical Treatment of ADHD
We obtain data on prescribed drugs used to treat ADHD from the Danish medical database. All pharmacies have since 1994 reported all redeemed prescriptions to Statistics Denmark (see Johannesdottir et al. 2012 for data description). It is possible to link redeemed prescriptions to individuals through their social security numbers. Because customers or patients must supply their social security numbers in order to obtain their prescriptions, these data are highly reliable.
In addition, the Danish Health and Medicine Authority oversee all Danish pharmacies, so we capture all redeemed prescriptions in our data. Through the population register, we can isolate all prescriptions redeemed by or for children in each municipality. We measure the ADHD medication rate as the number of children per 1,000 that have redeemed at least one prescription for medicine used to treat ADHD. We do not include individuals who receive a prescription but do not redeem it.
Other Explanatory Factors
In the macro-level portion of the analysis, we control for female and male incarceration rates, the the share of mothers employed; the share of missing, deceased, or unknown fathers; and average sibship size. We also control for municipality fixed effects.
EMPIRICAL APPROACH

Macro-level Model
Our macro-level sample consists of annual observations of foster care caseloads, ADHD medication rates, and a set of covariates. The data have a panel format with annual observations (t) nested within municipalities (j). We regress the log of foster care caseloads measured as the number of children in foster care per 1,000 on the number of children per 1,000 medicated for ADHD, a set of time-varying municipality characteristics, and municipality fixed effects 5 and year fixed effects. 6 The municipal level is the lowest level available to us if we are to credibly link the child population with their experienced geographical medication-level. Once we account for both varying and fixed municipality characteristics, we assume that the variation in ADHD medication rates is caused by stochastic variation in the diffusion of the use of Ritalin and similar drugs throughout municipalities. This leads to the following macro-level model:
where δ captures the impact of ADHD medication rates on foster care caseloads.
As previously discussed, the increase in ADHD medication usage was limited to older children, so including young children may only contribute with statistical noise. 7 Therefore, we also estimate equation 1 using only foster care caseloads and ADHD treatment share for children aged 6 to 17. If the rise in ADHD medication caused foster care caseloads to drop, we should expect to see a more pronounced and statistically significant effect when only examining the limited but actually treated age group.
A final concern is that social services may have chosen to treat children for ADHD because they did not place the children in foster care (reverse causality). As discussed previously, there is little evidence that this will be the case. Nevertheless, if the drop in foster care caseload rates led to more children receiving medication or if a common factor affected foster care caseloads negatively and ADHD medication rates positively, that would bias our estimates. To examine whether reverse causality or confounding drive our results, we also estimate a model using one year lagged ADHD rates as our predictor of interest. (We also include two and three year lagged variables as controls for the municipality-specific trend in ADHD prescription in this model.)
Individual Level Risk
Whereas our macro-level model provides a strong test of the association between medical treatment of ADHD and caseloads, it remains vulnerable to the ecological inference problem (e.g., Drake et al. 2003) . To provide a test at a lower level of aggregation, we use a randomly drawn 10 percent sample of all Danish children aged 6 to 17 from 1998-2010, which leaves us with a large but computationally manageable number of observations (157,938 children observed 1,016,286 times). The outcome is foster care placement. We use a one year lagged indicator on municipal ADHD load (calculated at the individual level to take movement between municipalities into account), individual level information on parental characteristics, and municipality fixed effects. We obtained all data from Statistics Denmark. Table A1 presents all sample statistics.
The individual-level models assess the impact of increased ADHD medication use on the average risk of entering foster care. If medical treatment of ADHD directly affects the risk of being in care, the individual level effect of increases in ADHD medication on foster care risk should align closely to the estimated caseload level effect. In addition, the individual level data allow us to remove individual level fixed effects. This gives the model:
Foster care it is equal to 1 if the child i is in foster care at any time in year t, 0 otherwise.
Year t is the linear time term, ADHD it-1 is the ADHD-medication rate for the municipality the child lived in at year t-1, Xβ it is the set of child characteristics, and Zγ it is the set of municipality characteristics. We only include time as a linear term to avoid the age-period-cohort issue (e.g., Winship and Harding 2008) , and because our measure of medical treatment of ADHD becomes highly collinear with time once we control for municipality fixed effects. We use a one year lagged measure of ADHD-medication rate to further address any issues of simultaneity bias.
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RESULTS
We first present results from the macro-level models that examine the relationship between municipal level ADHD medication rates and foster care caseloads. We then submit our results to a number of robustness tests that take into account (a) that only children above a certain age are likely to receive medical treatment for ADHD; and (b) that time trends and ADHD medication rates are heavily intertwined. Last, we examine how ADHD medication rates affect the individual risk of being in foster care to address the ecological inference problem. Table 2 reports the results from the macro-level models. Model 1 shows that there is a strong negative relationship between the logarithm of foster care caseloads and the rate of children treated for ADHD, controlling for time-varying municipal level covariates. When including neither municipality nor time fixed effects, we find that increasing medication rates with 1 additional child per 1,000 leads to a 2.9 percent decrease in foster care caseloads (translating into roughly a 29 percent decrease per 1 percentage point increase in ADHD medication rates).
Macro-Level Results
[ Table 2 about here.]
When we control for both the time trend and the municipality fixed effects (model 2), which provides a more rigorous and appropriate test, the rate of medical treatment of ADHD is negatively and significantly associated with log foster care caseloads. Though the parameter estimate for ADHD is only -0.005, it is important to remember that (a) this is a lower bound estimate (see discussion below); and (b) the number of children who received medical treatment for ADHD rose from less than 1 in 1,000 in 1998 to almost 12 in 1,000 in 2010, leading this to still have a large effect at the aggregate level. For each additional child per 1,000 children who received medication for ADHD, foster care caseloads drops 0.5 percent (if we assume a constant semi-elasticity), meaning that, at the least, the 11 per 1,000 change in the rate of medical treatment of ADHD over this period decreased the number of foster care caseloads by 5.5 percent.
As discussed earlier, children under five almost never receive medication for ADHD and did not experience any rise in their medication rates (Dalsgaard et al. 2013a ). The youngest group of children therefore only contributed statistical noise to the results presented in model 1
and model 2, so in models 3-6, we replicate the analyses with medication rates only calculated for children ages 6-17 (model 3 and model 4), and with both medication rates and foster case caseloads only calculated for children ages 6-17 (models 5 and 6). shares when only examining children ages 6 to 17 (meaning the aggregate effect is similar).
To skip to the most rigorous models (models 4 and 6), the ADHD estimate for the model including both municipality and time effects are identical to the one found in model 2, but more statistically significant in the case of model 6. Because the range for the rate of medical treatment of ADHD is greater in models 3-6 than in models 1 and 2, coefficients that are roughly the same size across models have a larger impact in models 3-6 than in models 1 and 2. This age group experienced a rise in ADHD medication from just below 1 in 1,000 in 1998 to more than 15 in 1,000 in 2010 (see Figure A1 ). Assuming a constant elasticity across ADHD medication increases, we calculate that under this lower bound specification increased ADHD medication caused approximately a 7.5 percent decrease in foster care caseloads (which, again, is about a 2.0 percent greater decrease than predicted decrease based on the results from model 2). 9 In addition, since the parameter estimate for model 4 is similar to model 2, there might be positive externalities of treating one child for ADHD on siblings' risk of entering foster care.
The fact that we find larger and more statistically significant results after controlling for municipality fixed effects and time effects demonstrates that younger children only contribute statistical noise, as we hypothesized. Thereby, the results gives credence to the argument that increased use of ADHD medication directly affected foster care caseloads for older children.
Sensitivity Analyses
Using measures for foster care caseloads and ADHD prescription from the same year may cause issues of simultaneity bias. To address issues of reverse causality and confounding, we estimate the model using one, two, and three year lagged ADHD treatment share. All models shown include municipality fixed effects and time effects. We calculate the lagged medication rates at the individual level before aggregating them, thereby taking into account that parts of the child population might move between municipalities from year to year. Table 3 shows the lagged results. Models 1 to 3 show the results for the one year lagged ADHD variable for the full sample. The point estimates are similar to those in Table 2 but insignificant. Models 4 to 6 show results for the one year lagged ADHD variable for the sample of children age 6 to 17. The point estimates are similar to those shown in Table 3 and significant at the .10 level. Overall, results become weaker when using one year lagged ADHD medication rates, but ultimately support the conclusion even when also controlling for two and three year lagged ADHD medication rates.
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Micro-Level Results
Although our macro-level estimates provide robust results that indicate that increased medical treatment of ADHD leads to decreased foster care caseloads, the macro-level results are vulnerable to the ecological inference problem. To address this, we estimate individual level fixed effect models regressing whether a child was in foster care in any given year on ADHD medication rates in the child's municipality and a set of controls. We assume that variation in one year lagged ADHD medication load is exogenous once we have taken individual and municipality characteristics into account. We limit the sample to children ages 6-17.
11 Table 4 shows the results of the individual level fixed effect regressions. A rise in ADHD medication load causes a significant decrease in the risk of entering foster care when we only control for individual fixed effects, municipality fixed effects, and a linear time trend (model 1).
The estimate expresses the effect of an increase of 1 child per 100 receiving medical treatment for ADHD on the probability of being in foster care when not controlling for time varying observables. For every 1 child per 100 receiving medical treatment, the risk of being in foster care drops 0.8 percentage points. Controlling for municipality-and family-level characteristics does not substantially change the estimate. Calculating the individual level effect based on the increase in the use of ADHD medication among children ages 6-17 from 1998 to 2010 (from a municipal average of just below 1 in 1,000 to above 15 in 1,000) translates into a decrease in the risk of being in foster care of 1.05 percentage points. Measured against the share of children in the micro-level sample that was in foster care in 1998, we then calculate that increased use of ADHD medication caused a 33 percent decrease in the foster care placement of children ages 6-17 by 2010. We also estimated Bayesian tipping point models across the distribution of share of ADHD medicated to examine whether the effect decreases or even changes as ADHD medication shares increase, but we find no evidence of Denmark having reached a tipping point for the negative effect of ADHD medication rates on children's individual level foster care risk.
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[ Figure 3 indicates some autocorrelation between certain municipalities, so we re-run our model limiting the sample period to 1998-2006. We also control for general medicalization trends for children by including the municipal medication rates for antipsychotic drugs to capture any general trends (see Figure B2 in appendix for the development in the use of antipsychotic drugs). The results (see Table A3 in appendix) do not differ substantially from the results provided by the models that include the entire study period and does not control for antipsychotics. We also run additional robustness tests using the lagged municipal ADHD medication load as an instrument for whether an individual received medical treatment for ADHD a given year, and still find significant negative effects of ADHD treatment of the risk of being in foster care (see Table A4 in appendix). This test is uniquely appropriate and strong for a number of reasons. First, because we have registry data, which covers the entire Danish population and has virtually no attrition, our results
DISCUSSION
do not have to deal with the concerns about missing data endemic to research on the foster care system (and, to a lesser degree, medical treatment of ADHD). Second, because children in foster care have a much higher propensity for exhibiting behavioral problems such as ADHD than children in the general population, considering how the medical treatment of ADHD might modify the risk of foster care placement is an especially direct test of how factors that change children's behavioral problems may also modify their risk of foster care placement. Third, by modeling these processes both at the individual level and at the population level, we provide insight not only into what proportion of the decrease in foster care caseloads happening over this period is attributable to increases in medical treatment of ADHD, but also into whether these effects hold at the individual level, decreasing concerns about the ecological inference problem.
The results from our analyses show that increased medical treatment of ADHD likely significantly and substantially lowered foster care caseloads in Denmark. According to the estimates based on our preferred model, 45 percent of the decrease in foster care caseloads that took place in Denmark from 1998 to 2010 is attributable to the rise in the use of medical treatment for ADHD. Furthermore, even in arguably our most conservative macro level model (25 percent) and our micro level model (33 percent), we find pronounced associations between increases in ADHD medication on the decrease in foster care caseloads in Denmark, and our host of robustness tests makes it likely that the association is causal.
To consider the magnitude of these effects, in their seminal analysis of US foster care caseloads, Swann and Sylvester (2006) showed that increases in the female imprisonment rate, the factor that most strongly drove the increase in foster care caseloads in the United States from the mid-1980s to 2000, accounted for roughly 31 percent of the foster care boom over this period. Within this context, even the results from our models that provide evidence of smaller effects still suggest powerful effects. Indeed, the estimates provide range from 25 percent (for the most conservative macro level model) to 45 percent (for our preferred macro level model),
implying that the magnitude of effects we isolate here are well within the range Swann and Sylvester (2006) identify with shifts in female imprisonment and, moreover, go substantially beyond the effects of other factors they considered, such as shifts in welfare generosity.
In providing this strong, broad test, we make at least two major contributions. First, we provide the first test to show that interventions that lead to behavioral modification in children can fundamentally alter the foster care system. This finding is of the utmost importance not only because it suggests that some of the scarce governmental resources dedicated to child protective services could be directed toward interventions designed to alter children's behavior in ways that make them easier to parent (instead of focusing mostly on things that parents may need to change), but also because it suggests that other (non-medical) types of interventions designed to diminish children's behavioral problems could too have macro-level effects, a possibility little research to date has considered (to our knowledge).
Second, it shows that while the concerns about social control and the social construction of problem behaviors voiced by some medical sociologists are invaluable (e.g., Conrad 1975 Conrad , 1992 Conrad , 2005 , there is a point at which medical treatment of behavioral problems holds great value not only for the children themselves and their families, but also for the broader society. A parallel may be in order here in terms of imprisonment which, like the over-treatment of ADHD through medication, has received a tremendous amount of attention, much of it critical, from scholars of social control (e.g., Wacquant 2001; Western 2006) . Largely missing from the discussions of imprisonment in the United States, however, is the idea that at low levels, imprisonment is quite likely to be a societal good, and that it is only when the rate of imprisonment becomes high-and highly concentrated-that it starts to exert grave social costs (for a broader discussion, see Clear
2007
). In addition, society might benefit additionally from properly identifying the group that should receive treatment, be it imprisonment or medical treatment for ADHD, rather than just ascribing it to a broad group of the population. Thus, our results are broadly consistent with what we expect to see in terms of imprisonment: while too much might have a host of societal costs, a small amount targeted at a well-defined group might do much good.
Although each of these conclusions is important in its own right, this study nonetheless has four key limitations. First, our analyses offer little insight into what the optimal level of medical treatment of ADHD might be. Denmark and the US may be on opposite sides of an optimal tipping point of treatment levels, or they may be treating vastly different types of children altogether. Second, although we provided strong tests at both the macro-level and the microlevel, we rely on municipal variation to provide an exogenous shock in medical treatment of ADHD, which may suffer from some degree of confounding. This is, to be sure, an important limitation. Third, although our analyses considered how municipality-level rates of medical treatment of ADHD affected individual-level risks of foster care placement, we lack an individual-level test that directly models how receiving medical treatment for ADHD affects children's risk of foster care placement beyond using the municipal variation as an instrumental variable. Finally, the Danish foster care system and the American system differ in many regards, including (but not limited to) the fact that the Danish system includes more teenagers, that having children in foster care (or being in foster care) appears to be less stigmatized in Denmark than in the US, and that more Danish children are placed in foster care at the request of their parents than is the case in the US. Thus, it remains unclear how well the analyses presented here would translate to the American context.
Limitations aside, this article has provided the first strong test of how the widespread use of medical treatment of ADHD could improve children's behaviors in ways so substantial as to be discernible at the macro level. The results are also important because they show that a medical treatment now widely considered to be used too liberally in the US has benefits when used at a modest level. And the results thus show that while the concern among medical sociologists and sociologists of social control about over-prescriptions are well-taken, the benefits of the medical treatment of ADHD through the use of drugs such as Ritalin for children's behavioral problems are, quite simply, too large to ignore, provided relatively few children receive the treatment.
ENDNOTES
1 A similar American study found that up to 75% of children in foster care received their ADHD diagnoses prior to their placement, suggesting behavioral problems may precipitate foster care placement (McMillen et al. 2005) .
2 Sociologists began to study medicalization of "hyperkinetic" children in the 1970s (Conrad 1975) , building upon theories of deviance and social control (e.g. Foucault 1965 ). This research viewed medicalization as a depoliticization and individualization of social problems through medical social control prescribed by a system of medical professionals, medical technologies, and pharmaceutical companies (e.g. Conrad 1998; 2005) . According to those working in this tradition, therefore, over-medicalization can do individuals serious harm because it re-labels and "sickens" normal responses to situations (e.g. Horwitz and Wakefield 2007) . 3 This includes amphetamine, dexamphetamine, dextromethamphetamine, methylphendiate, atomoxetine, dexmethylphendiate, and lisdexamfetamine. Unlike in the US, Adderall is not available as a prescription drug, and the most common drug prescribed is Ritalin (Pottegård et al. 2013 ). Some of the drugs listed are also used to treat children with autism spectrum disorders (ASD). Dalsgaard et al. (2013a) show that 16 percent of Danish children with ASD receive one of these medications. 4 We drop 16 observations of municipalities with fewer than 100 children in a given year. where we include number of children in the municipality on the RHS to examine whether we should weight our model, and find that weighting would not benefit our model. 7 The increase was 25 percent higher in the sample of children ages 6-17.
8 A different approach would be to use a hierarchical model that captures cohort and individual level effects as random parameters. This would give us more information on the cohort effect, but we already know from Figure 1 that entrance rates into foster care is decreasing between cohorts, and the additional information gained from modeling this explicitly are of little interest.
We also have no interest in testing the effect of fixed individual traits such as gender or ethnicity (see Yang and Land 2008 for discussion) . Thus, we use fixed effect models. 9 If we allow for more decimals on the estimates, we find that the estimate for ADHD medication rate in model 6 is actually lower than the estimate for model 2 (0.00497 against 0.00538).
Nevertheless, as the mean for the dependent variable is 35 percent higher in model 6 than in model 2 this does not significantly influence our interpretation. 10 To test whether a general uptake in medicalization among low-SES groups drives our results,
we also run our analyses controlling for the rate of children receiving medical treatment with antipsychotics. The results (see Table A2 in appendix) do not indicate that a general increase in medicalization drives our results. 11 We also run the micro-level model for only children ages 0-5. If the ADHD measure is capturing a different underlying process that generally led to lower foster care rates, we should see a negative association between ADHD medication rates and foster care rates for this group as well. The results (not shown here but available) find no significant association between ADHD medication rates and the risk of being in foster care for children ages 0-5. 12 Result available upon request. Source: Own calculations on data from Statistics Denmark.
